Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1138 | 1013 | 1179 | 1376 | 1557 | 2381 |
Fund Return | 13.75% | 1.25% | 17.92% | 11.22% | 9.26% | 9.06% |
Place in category | 757 | 1320 | 593 | 619 | 638 | 347 |
% in Category | 32 | 60 | 26 | 35 | 41 | 34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LansfOrsakringar Global Indexnara | 112.6B | 21.32 | 14.68 | 13.97 | ||
Lansforsakringar USA Indexnara | 44.8B | 25.06 | 17.54 | 17.06 | ||
Lansforsakringar Sverige Indexnara | 37.62B | 15.28 | 5.61 | 10.21 | ||
Lansforsakringar Fastighetsfond A | 25.44B | 14.99 | -5.22 | 14.28 | ||
Lansforsakringar Global Hallbar A | 23.36B | 20.93 | 12.32 | 12.24 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SPP Aktiefond Europa | 18.24B | 14.95 | 11.96 | 9.38 | ||
Swedbank Robur Access Europa | 15.66B | 13.70 | 12.69 | 9.36 | ||
Handelsbanken Europafond Index | 14.33B | 14.98 | 11.70 | 9.30 | ||
Handelsbanken European Index utd | 14.33B | 14.98 | 11.70 | 8.82 | ||
AMF Aktiefond Europa | 8.52B | 13.34 | 10.26 | 9.36 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.67 | 768.9 | +0.76% | |
ASML Holding | NL0010273215 | 4.47 | 627.10 | +0.95% | |
AstraZeneca | GB0009895292 | 3.65 | 11,022.0 | -0.18% | |
Novartis | CH0012005267 | 3.30 | 95.49 | +1.80% | |
Roche Holding Participation | CH0012032048 | 3.26 | 273.10 | +1.94% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review